Journal profile · Oncology
ONCOLOGY RESEARCH
ISSN 0965-0407 · eISSN 1555-3906 · TECH SCIENCE PRESS · UNITED STATES · Monthly · Founded 1992
ONCOLOGY RESEARCH: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.65; fully open access; no APC; median 93 days to acceptance (120 articles, last 24 months); community-reported acceptance: about 75%; 251 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
ONCOLOGY RESEARCH is published by TECH SCIENCE PRESS and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Circular RNAs in diseases, together about 37.1% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Open access (OA) refers to free and unrestricted online access to scientific and scholarly information. The concept of open access was firstly defined by the Budapest Open Access Initiative (BOAI). Tech Science Press (TSP) defines open access as follows: for articles published under an open access route, the peer-reviewed Version of Record is freely available online immediately upon publication (no embargo period), and may be reused in accordance with the applicable Creative Commons license, provided a correct citation to the original publication is given and any changes are indicated.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Enrico MiniPublisher website
Editorial board by country: none in mainland China; most named United States 15, Hong Kong, China 3, United Kingdom 3, South Korea 2, Taiwan, China 1 (29 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology13.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology13.2%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology10.7%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.9%
- Ferroptosis and cancer prognosisMedicine4.7%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.1%
- Cancer Cells and MetastasisMedicine3.8%
- Cancer Immunotherapy and BiomarkersMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2020 edition (medium risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
MEDLINEPMCEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Portico
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.65LetPub ·
- Impact factor (publisher) 2025
- 4.6Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 52LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 1,126OpenAlex ·
- 2-year mean citedness
- 2.54OpenAlex ·
- Self-citation rate
- 2.2%LetPub ·
- Share of gold OA articles
- 57.05%LetPub ·
Volume
- Articles per year
- 232LetPub ·
- Articles per year (publisher)
- 2,020Publisher website ·
Articles by year OpenAlex count · 2,228 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 316 | 308 | 95 |
| 2025 | 251 | 251 | 620 |
| 2024 | 225 | 224 | 1,297 |
| 2023 | 105 | 105 | 1,412 |
| 2022 | 34 | 34 | 417 |
| 2021 | 61 | 58 | 618 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
93 daysMedian, submission to acceptance · P25–P75 68 days – 121 days
- Acceptance to online
- median 63 days (120 articles)
- Submission to online
- median 159 days
- Sample
- 120 articles with submission and acceptance dates (630 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 200–400 words
- Keywords
- 3–10
- Reference style
- Vancouver
- Suggested reviewers
- Optional
- Cover letter
- Required
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access
- AI use Use of AI Tools by Authors
Authors may use AI tools to support manuscript preparation or research. Such tools must not replace the authors’ own expertise, critical analysis, interpretation, or judgement. Authors must maintain meaningful human oversight and remain fully responsible for the accuracy, originality, integrity, and compliance of the submitted and published work. All AI-assisted content, including citations and re…
Source ↗Publisher website ·- Authorship Author Contributions
The Author Contributions statement is mandatory for research articles, except for papers with a single author. It should represent all the authors and is to be included upon submission. All listed authors must have substantially contributed to the manuscript and have approved the final submitted version, which should include a description of each author’s specific work and contribution. We suggest…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
Declare conflicts of interest or state: “The author(s) declare(s) no conflicts of interest to report regarding the present study”.
Source ↗Publisher website ·- Data availability Data Sharing
Researchers share their data so that other researchers can replicate and build on their published claims. We encourage authors to share the data described and discussed in their articles. Research data can be uploaded to repositories and the access information provided in a published article or appended to the article in supplementary files. Any restrictions on the availability of research materia…
Source ↗Publisher website ·- License & copyright Copyright and Licensing
Oncology Research publishes all articles under an open-access license, which means that the articles remain accessible to all without charge and without technical or legal barriers and that they can be reused with proper acknowledgment and citation. Financial support for the open access publication is provided by the authors’ institutions or by research funding agencies in the way of article proce…
Source ↗Publisher website ·- Open access OR Open Access
Oncology Research ISSN:0965-0407 (print) ISSN:1555-3906 (online) Publication Frequency:Monthly
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- TECH SCIENCE PRESS
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1992
- ISSN
- 0965-0407
- Electronic ISSN
- 1555-3906
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ONCOLOGY RESEARCH
What CAS zone is ONCOLOGY RESEARCH in?
In the 2025 upgraded edition of the CAS Journal Ranking, ONCOLOGY RESEARCH is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ONCOLOGY RESEARCH?
The latest impact factor listed by LetPub is 4.65; CiteScore 4.1, h-index 69.
How long does peer review take at ONCOLOGY RESEARCH?
Based on the dates recorded on 120 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 68–121 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ONCOLOGY RESEARCH?
According to the journal's author guidelines: Abstract: 200–400 words; Keywords: 3–10; Reference style: Vancouver; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ONCOLOGY RESEARCH based?
Of the 29 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (15), Hong Kong, China (3) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index ONCOLOGY RESEARCH?
According to LetPub and DOAJ records, ONCOLOGY RESEARCH is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PMC and Embase; that list has not been checked against each database.
Is ONCOLOGY RESEARCH open access, and what is the APC?
ONCOLOGY RESEARCH is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .